treatment mesangi iga nephropathi cyclophosphamid dipyridamol warfarin two-year prospect trial patient mesangi iga nephropathi treatment cyclophosphamid month dipyridamol warfarin year treatment random prospect studi entri treat untreat group patient mean serum creatinin urinari protein excret quantit urinari erythrocyt count blood pressur read end trial mean sem creatinin valu mmol/l untreat patient mmol/l treat patient mean sem log valu urinari erythrocyt rbc count log rbc/ml untreat patient log rbc/ml treat patient treat patient mean sem urinari protein excret wherea untreat patient urinari protein unchang initi valu follow-up No signific chang blood pressur group studi observ treatment iga cyclophosphamid dipyridamol warfarin reduct urinari protein excret signific effect preserv renal function serum creatinin valu two-year studi 